Miseqdx Cystic Fibrosis 139-variant Assay (2018-02-13)
MiSeqDx Cystic Fibrosis 139-Variant Assay Recall Illumina's MiSeqDx Cystic Fibrosis 139-Variant Assay, a genetic test used to detect cystic fibrosis mutations, has been recalled across Canada. The recall was issued because of issues with the medical device itself. This is a Class I recall, meaning there is a serious potential health risk, and the product was distributed throughout Canada.
- Reason
- Medical devices
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DEVICES
- Recall date
- 2018-02-22
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DEVICES
Recall details on Nibble Recalls: https://trynibble.app/recalls/6ade950e-1e2c-48e8-80c5-cd7ae7210856